Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer
Oncology Reports · 03.07.2024 · 52 (2)
DOI: 10.3892/or.2024.8769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 03.07.2024. Verfasst von Xue Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, P.R. …. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Twist-Related Protein 1, Nuclear Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, P.R. China.
Zitieren
APA
Peng, X., Ma, L., Chen, X., Tang, F., & Zong, X. (2024). Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer. Oncology Reports, 52(2). https://doi.org/10.3892/or.2024.8769
Vancouver
Peng X, Ma L, Chen X, Tang F, Zong X. Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer. Oncology Reports. 2024;52(2). doi:10.3892/or.2024.8769
BibTeX
@article{Peng2024,
author = {Peng, Xue and Ma, Lisi and Chen, Xuan and Tang, Fen and Zong, Xiangyun},
title = {Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer},
journal = {Oncology Reports},
year = {2024},
volume = {52},
number = {2},
doi = {10.3892/or.2024.8769}
}
EUVIMED